6533b7cffe1ef96bd12599b2

RESEARCH PRODUCT

Interference of carbidopa and other catechols with reactions catalyzed by peroxidases

Krystyna Hirsz-wiktorzakAnna RybczyńskaHubert WojtasekToshimasa YamazakiYuki NishigayaBeata Gąsowska-bajger

subject

0301 basic medicineParkinson's diseaseBiophysicsCatecholsperoxidaseBiochemistryHorseradish peroxidaseCatalysis03 medical and health scienceschemistry.chemical_compoundmedicineAnimalsHumansLactoperoxidasecarbidopaHydrogen peroxideenzymatic assay interferenceMolecular BiologyHorseradish PeroxidaseCatecholABTS030102 biochemistry & molecular biologybiologyMolecular StructureMonophenol MonooxygenaseLactoperoxidasehydrazineHydrogen PeroxidecatecholAscorbic acidCombinatorial chemistryMolecular Docking Simulation030104 developmental biologychemistryChromogenic CompoundsPeroxidasesCarbidopabiology.proteinParkinson’s diseaseCattleOxidation-Reductionmedicine.drugPeroxidase

description

Abstract Background A number of compounds, including ascorbic acid, catecholamines, flavonoids, p-diphenols and hydrazine derivatives have been reported to interfere with peroxidase-based medical diagnostic tests (Trinder reaction) but the mechanisms of these effects have not been fully elucidated. Methods Reactions of bovine myeloperoxidase with o-dianisidine, bovine lactoperoxidase with ABTS and horseradish peroxidase with 4-aminoantipyrine/phenol in the presence of carbidopa, an anti-Parkinsonian drug, and other catechols, including l -dopa, were monitored spectrophotometrically and by measuring hydrogen peroxide consumption. Results Chromophore formation in all three enzyme/substrate systems was blocked in the presence of carbidopa and other catechols. However, the rates of hydrogen peroxide consumption were not much affected. Irreversible enzyme inhibition was also insignificant. Conclusions Tested compounds reduced the oxidation products or intermediates of model substrates thus preventing chromophore formation. This interference may affect interpretation of results of diagnostic tests in samples from patients with Parkinson's disease treated with carbidopa and l -dopa. General significance This mechanism allows prediction of interference in peroxidase-based diagnostic tests for other compounds, including drugs and natural products.

10.1016/j.bbagen.2018.04.007https://www.sciencedirect.com/science/article/pii/S0304416518301004?via=ihub